SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-206655
Filing Date
2024-08-26
Accepted
2024-08-26 07:07:00
Documents
15
Period of Report
2024-08-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d866047d8k.htm   iXBRL 8-K 33877
2 EX-10.1 d866047dex101.htm EX-10.1 63626
6 GRAPHIC g866047g0823073604553.jpg GRAPHIC 4866
  Complete submission text file 0001193125-24-206655.txt   248981

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elym-20240826.xsd EX-101.SCH 2838
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elym-20240826_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elym-20240826_pre.xml EX-101.PRE 11250
17 EXTRACTED XBRL INSTANCE DOCUMENT d866047d8k_htm.xml XML 3651
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 241237729
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)